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A 31-year-old internal medicine regis-
trar presented with dyspnoea on
exertion and low-grade fever. He had
a history of COVID-19 pneumonia
and was discharged 3 weeks previ-
ously. He did not have any other spe-
cific past medical history. At his
previous admission, RT–PCR was pos-
itive for SARS-CoV-2, lung CT (Panel
A) showed bilateral ground-glass and
consolidative opacities mostly in the
right lower zone, and the laboratory
data showed high C-reactive protein
(CRP) levels of 105 mg/L and erythro-
cyte sedimentation rate (ESR) of 70
mm/h but normal high sensitivity tro-
ponin T of<0.03 ng/mL. In the second
week, he experienced pleuritic chest
pain with no ECG changes. Troponin
was not checked at that time. He was
discharged after 10 days with two sub-
sequent negative RT–PCRs and in
good condition. CT at discharge
(Panel B) showed significant resolution
of consolidation with bilateral multifo-
cal ground-glass appearance.
Three weeks after discharge, he
presented with dyspnoea on exertion
and low-grade fever. On examination,
he had a blood pressure of 110/80
mmHg, respiratory rate 18 breaths/
min, heart rate 70 b.p.m., temperature
37.8C (axillary), and O2 Sat 96%.
Blood cell count (CBC) was normal,
CRP was 3.3 mg/L, and high sensitivity
troponin T was <0.03 ng/mL. RT–
PCR was negative for SARS-CoV-2. A
12-lead electrocardiogram was nor-
mal. The transthoracic echocardiogra-
phy had a poor acoustic window but
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revealed mild left ventricular (LV) dysfunction. Cardiac magnetic resonance revealed normal LV size with mildly reduced ejection fraction
(LVEF) of 50% (Supplementary material online, Video S1). T2-weighted oedema sequence with its post-analysis T2 ratio (Panel C and D)
showed oedema/inflammation in the mid inferoseptal and inferior wall. Late gadolinium enhancement (Panel E and F) showed subepicardial
fibrosis in the mid inferior wall. The clinical and imaging features were suggestive for active myocarditis. The patient was clinically stable with
no arrhythmia or signs of heart failure, so we did not perform an endomyocardial biopsy. Other serological tests for Coxsackie, Parvovirus
B19, Epstein–Barr, and human herpesvirus were negative. The myocarditis could be residual myocardial inflammation as a result of COVID-
19, and the cardiac involvement might be overlooked during pneumonia. Medical treatment was started with bisoprolol and lisinopril.
Supplementary material is available at European Heart Journal Cardiovascular Imaging online.
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